# FDA Inspection 1016403 - Samer Nakhle, M.D. - June 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/samer-nakhle-md/6c19aec9-c761-4707-98bb-ac6148bad3d8
Source feed: FDA_Inspections

> FDA Inspection 1016403 for Samer Nakhle, M.D. on June 30, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016403
- Company Name: Samer Nakhle, M.D.
- Inspection Date: 2017-06-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1309236 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/samer-nakhle-md/3b2a399a-3942-4f69-8763-280e28b76e31)

Company: https://www.keypedia.com/companies/samer-nakhle-md/8939cfe3-6e8a-447d-a8fc-757e3cc18bf5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c